How much funding has Glooko raised?

Glooko has raised $231.5M in total funding, most recently a Series F round.

Who are Glooko's investors?

Glooko's investors include Georgian, Health Catalyst Capital, Canaan Partners, Novo Nordisk, Medtronic, Samsung Venture Investment Corporation.

Where is Glooko headquartered?

Glooko is headquartered in Palo Alto, California, United States.

Glooko

We're transforming diabetes across the full continuum of care.

Palo Alto, United States · Founded 2010 · $231.5M raised

Healthcare

Headquarters: Palo Alto, California
Employees: 201–500
Founded: 2010
Business Model: B2B

Website: glooko.com
Total Funding: $231.5M
Last Round: $100.0M Series FOct 2024
Rounds: 8

About

Glooko is a global digital health company providing the leading diabetes management platform. It integrates data from 200+ diabetes and health monitoring devices, enabling remote patient monitoring and population health management for healthcare providers, hospitals, and health systems. The platform offers clinical workflow tools, EHR integration, and analytics to help clinicians manage large patient populations, while giving patients with diabetes comprehensive visualizations and secure collaboration with their care teams. Glooko holds multiple industry-leading security certifications including HITRUST, SOC 2 Type II, ISO 27001, and is HIPAA and GDPR compliant. Deployed in 30+ countries and 8,000+ clinical locations.

Summary

Glooko is a Healthcare company based in Palo Alto, United States, founded in 2010. It has raised $231.5M in total across 8 rounds, most recently a $100.0M Series F round in Oct 2024. Investors include Georgian, Health Catalyst Capital and Canaan Partners.

LinkedIn X (Twitter)